报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 70.07% | -4.38% | 4.88% | 30/54 | 69.26% | 我武生物 | 95.26% | 行业排名> |
2024-06-30 | 66.81% | -11.23% | -4.42% | 32/54 | 68.54% | 西藏药业 | 95.7% | 行业排名> |
2024-03-31 | 69.91% | -2.96% | -3.68% | 31/54 | 69.17% | 康华生物 | 95.85% | 行业排名> |
2023-12-31 | 72.57% | 24.88% | -0.97% | 28/54 | 68.3% | 我武生物 | 95.26% | 行业排名> |
2023-09-30 | 73.28% | 10.68% | -2.63% | 28/54 | 68.07% | 我武生物 | 95.4% | 行业排名> |
2023-06-30 | 75.26% | 7.85% | 4.48% | 25/54 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
2023-03-31 | 72.04% | -6.34% | 23.96% | 28/54 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
2022-12-31 | 58.12% | -39.3% | -12.23% | 36/54 | 68.27% | 我武生物 | 95.39% | 行业排名> |
2022-09-30 | 66.21% | -30.51% | -5.12% | 33/54 | 71.28% | 我武生物 | 95.63% | 行业排名> |
2022-06-30 | 69.79% | -27.56% | -9.27% | 30/54 | 69.18% | 我武生物 | 95.75% | 行业排名> |
2022-03-31 | 76.92% | -15.07% | -19.66% | 26/54 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
2021-12-31 | 95.74% | 7.3% | 0.48% | 1/54 | 72.33% | 百奥泰 | 95.74% | 行业排名> |
2021-09-30 | 95.29% | 7.29% | -1.08% | 2/54 | 73.87% | 我武生物 | 95.89% | 行业排名> |
2021-06-30 | 96.33% | 11.69% | 6.36% | 1/54 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
2021-03-31 | 90.57% | 3.96% | 1.49% | 6/54 | 73.03% | 义翘神州 | 96.83% | 行业排名> |
2020-12-31 | 89.23% | 9.15% | 0.47% | 13/54 | 71.61% | 义翘神州 | 96.88% | 行业排名> |
2020-09-30 | 88.82% | 8.65% | 2.99% | 9/54 | 73.64% | 义翘神州 | 96.56% | 行业排名> |
2020-06-30 | 86.24% | 2% | -1% | 16/54 | 88.2% | 华兰疫苗 | 707.43% | 行业排名> |
2020-03-31 | 87.11% | 2% | 6.56% | 12/54 | 70.26% | 我武生物 | 95.6% | 行业排名> |
2019-12-31 | 81.75% | 2% | 0% | 24/54 | 72.44% | 我武生物 | 96.43% | 行业排名> |
2019-09-30 | 81.75% | 2% | 2% | 14/54 | 70.09% | 我武生物 | 96.51% | 行业排名> |